Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
chlorpromazine
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Generic mfg.
Drug class:
DRD2 antagonist, DRD3 antagonist, DRD4 antagonist, Serotonin 1A-2A-2B-2C receptor antagonist
Related drugs:
‹
ONC201 (5)
zuclopenthixol (1)
fluphenazine (1)
ONC206 (0)
olanzapine (0)
ONC201 (5)
zuclopenthixol (1)
fluphenazine (1)
ONC206 (0)
olanzapine (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
MGMT unmethylation
Glioblastoma
MGMT unmethylation
Glioblastoma
chlorpromazine
Sensitive: C3 – Early Trials
chlorpromazine
Sensitive
:
C3
chlorpromazine
Sensitive: C3 – Early Trials
chlorpromazine
Sensitive
:
C3
EGFR T790M
Non Small Cell Lung Cancer
EGFR T790M
Non Small Cell Lung Cancer
chlorpromazine
Sensitive: D – Preclinical
chlorpromazine
Sensitive
:
D
chlorpromazine
Sensitive: D – Preclinical
chlorpromazine
Sensitive
:
D
EGFR exon 19 deletion
Non Small Cell Lung Cancer
EGFR exon 19 deletion
Non Small Cell Lung Cancer
chlorpromazine
Sensitive: D – Preclinical
chlorpromazine
Sensitive
:
D
chlorpromazine
Sensitive: D – Preclinical
chlorpromazine
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login